Cite
HARVARD Citation
Lorenzatti, A. et al. (2019). Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial. Diabetes, obesity & metabolism. 21 (6), pp. 1455-1463. [Online].